Skip to main content

Table 5 Percentage of patients on monotherapy at the end of biologic course, according to the biologic treatment course

From: Prevalence of biologics monotherapy in a cohort of patients with Rheumatoid Arthritis in daily clinical practice

  1st Course 2nd Course 3rd Course 4th Course Total
Number of patients 79 25 9 2 115
% Patients on biologic monotherapy at the end of the course (95 % CI) 25 (16–36) 52 (31–72) 44 (14–79) 50 (13–99) 33 (24–42)
% Patients on biologic monotherapy at the end of the course due to Medical prescription (95 % CI) 20 (12–31) 40 (21–61) 33 (7–70) 50 (13–99) 25 (17–34)
% Patients biologic monotherapy at the end of the course due to patient’s decision (95 % CI) 5 (1–12) 12 (2.5–31) 11 (0.3–48) 0 8 (4–14)